InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: chickpea598 post# 35031

Thursday, 04/14/2016 1:13:28 PM

Thursday, April 14, 2016 1:13:28 PM

Post# of 48316
To be honest I do not see ONCS turning into a big pharma. I think if and after combo efficiency and value are proven in melanoma, Merck will buy it out paying a premium for other indications which it can further on its own. I do not want to stay for 3-4 years for each indication. A lump sum buyout would be fine by me.